Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Research Support, U.S. Gov't, P.H.S.

Clinical Trial

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Research Support, U.S. Gov't, Non-P.H.S.

Controlled Clinical Trial

Multicenter Study

Publication Year

From

Quick links

Individual year

2016

2011

2010

2008

2006

2005

2004

2003

2002

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Hemocyanins""[mesh_terms]

11 Results

Searching titles within these results

Characterisation of the clinical and activated T cell response to repeat delayed-type hypersensitivity skin challenges in human subjects, with KLH and PPD, as a potential model to test T cell-targeted therapies.

Disala Fernando, Tim Schmidt, Alexandra Belson, Kelly Hardes, Nicola Scott, Sara Brett, Deborah Clark, João Joaquim Oliveira, Bill Davis, Simon McHugh, John Stone

Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2016;65(5):389-404

Full Text

Abstract

Radiation dose reduction and image enhancement in biological imaging through equally-sloped tomography.

Edwin Lee, Benjamin P Fahimian, Cristina V Iancu, Christian Suloway, Gavin E Murphy, Elizabeth R Wright, Daniel Castaño-Díez, Grant J Jensen, Jianwei Miao

Journal of structural biology 2010;164(2):221-7

Free Full Text

Abstract

Bacterial tyrosinases.

Heinz Decker, Harald Claus

Systematic and applied microbiology 2006;29(1):3-14

Full Text

Abstract

The crystal structure of catechol oxidase: new insight into the function of type-3 copper proteins.

Christoph Eicken, Bernt Krebs, Carsten Gerdemann

Accounts of chemical research 2003;35(3):183-91

Full Text

Abstract

Cardiovascular exercise intervention improves the primary antibody response to keyhole limpet hemocyanin (KLH) in previously sedentary older adults.

R W Grant, R A Mariani, V J Vieira, M Fleshner, T P Smith, K T Keylock, T W Lowder, E McAuley, L Hu, K Chapman-Novakofski, J A Woods

Brain, behavior, and immunity 2008;22(6):923-32

Free Full Text

Abstract

Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1.

Cristina Musselli, Govindaswami Ragupathi, Teresa Gilewski, Katherine S Panageas, Yael Spinat, Philip O Livingston

International journal of cancer 2002;97(5):660-7

Full Text

Abstract

Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.

Govind Ragupathi, Philip O Livingston, Chandra Hood, John Gathuru, Susan E Krown, Paul B Chapman, Jedd D Wolchok, Linda J Williams, Roberta C Oldfield, Wen-Jen Hwu

Clinical cancer research : an official journal of the American Association for Cancer Research 2004;9(14):5214-20

Full Text

Abstract

Glutamine-enriched enteral nutrition increases in vitro interferon-gamma production but does not influence the in vivo specific antibody response to KLH after severe trauma. A prospective, double blind, randomized clinical study.

Petra G Boelens, Alexander P J Houdijk, Johanna C M Fonk, Juan C Puyana, Henk J Th M Haarman, Mary E von Blomberg-van der Flier, Paul A M van Leeuwen

Clinical nutrition (Edinburgh, Scotland) 2004;23(3):391-400

Full Text

Abstract

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

T Gilewski, S Adluri, G Ragupathi, S Zhang, T J Yao, K Panageas, M Moynahan, A Houghton, L Norton, P O Livingston

Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1693-701

Full Text

Abstract

Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses.

Geertrude H Struijk, Robert C Minnee, Sven D Koch, Aeilko H Zwinderman, Karlijn A M I van Donselaar-van der Pant, Mirza M Idu, Ineke J M ten Berge, Frederike J Bemelman

Kidney international 2011;78(9):934-40

Free Full Text

Abstract

Current and new strategies in immunotherapy for superficial bladder cancer.

Stefan C Müller, Frank G E Perabo

Urology 2005;64(3):409-21

Full Text

Results: 1 – 11 / 11

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Hemocyanins""[mesh_terms]

Characterisation of the clinical and activated T cell response to repeat delayed-type hypersensitivity skin challenges in human subjects, with KLH and PPD, as a potential model to test T cell-targeted therapies.

Radiation dose reduction and image enhancement in biological imaging through equally-sloped tomography.

Bacterial tyrosinases.

The crystal structure of catechol oxidase: new insight into the function of type-3 copper proteins.

Cardiovascular exercise intervention improves the primary antibody response to keyhole limpet hemocyanin (KLH) in previously sedentary older adults.

Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1.

Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.

Glutamine-enriched enteral nutrition increases in vitro interferon-gamma production but does not influence the in vivo specific antibody response to KLH after severe trauma. A prospective, double blind, randomized clinical study.

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses.

Current and new strategies in immunotherapy for superficial bladder cancer.

Results for
""Hemocyanins""[mesh_terms]